other monoclonal antibodies are described ( aml-2-23 and aml-2-9 ) that mediate complement-dependent cytotoxicity to myeloid leukemia cells as well as selected normal cell types ( monocytes and lymphocytes , respectively ) .
C0023467
aml
C0024264
lymphocytes